These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 17175892)

  • 1. Method comparison of cardiac marker assays on PATHFAST, StratusCS, AxSYM, Immulite 2000, triage, elecsys and cardiac reader.
    Peetz D; Schweigert R; Jachmann N; Post F; Schinzel H; Lackner KJ
    Clin Lab; 2006; 52(11-12):605-14. PubMed ID: 17175892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the chemiluminescence immunoassays for the measurement of troponin I, myoglobin and CK-MB using the IMMULITE system in comparison to other measuring systems.
    Lestin M; Hergert M; Lestin HG; Brinker C; Storm H; Kuhrt E; Kuhrt B; Lambrecht HG; Kühnel W
    Clin Lab; 2002; 48(3-4):211-21. PubMed ID: 11934224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [NT-proBNP measurement on Immulite 2500 (DPC): analytical performance and comparison with Roche Diagnostics and Dade-Behring NT-proBNP immunoassays].
    Cauliez B; Boucher S; Duflo-Leroy A; Lavoinne A
    Ann Biol Clin (Paris); 2007; 65(1):93-8. PubMed ID: 17264046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization of cardiac markers.
    Apple FS
    Scand J Clin Lab Invest Suppl; 2005; 240():107-11. PubMed ID: 16112967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical performance of time-resolved fluorometry-based Innotrac Aio! cardiac marker immunoassays.
    Hedberg P; Valkama J; Puukka M
    Scand J Clin Lab Invest; 2003; 63(1):55-64. PubMed ID: 12729070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction.
    Wu AH; Smith A; Christenson RH; Murakami MM; Apple FS
    Clin Chim Acta; 2004 Aug; 346(2):211-9. PubMed ID: 15256323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the analytical performance characteristics of NT-proBNP immunoassay on dimension RxL-HM (Dade Behring)].
    Benoit MO; Dautezac F; Taccoen M; Paul JL
    Ann Biol Clin (Paris); 2005; 63(4):411-6. PubMed ID: 16061439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre analytical evaluation of a new point-of-care system for the determination of cardiac and thromboembolic markers.
    Bertsch T; Chapelle JP; Dempfle CE; Giannitsis E; Schwabs M; Zerback R
    Clin Lab; 2010; 56(1-2):37-49. PubMed ID: 20380358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay.
    Lee-Lewandrowski E; Januzzi JL; Green SM; Tannous B; Wu AH; Smith A; Wong A; Murakami MM; Kaczmarek J; Apple FS; Miller WL; Hartman K; Jaffe AS
    Clin Chim Acta; 2007; 386(1-2):20-4. PubMed ID: 17854790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease testing on the Dimension Vista system: biomarkers of acute coronary syndromes.
    Kelley WE; Lockwood CM; Cervelli DR; Sterner J; Scott MG; Duh SH; Christenson RH
    Clin Biochem; 2009 Sep; 42(13-14):1444-51. PubMed ID: 19523464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Abbott AxSYM and Roche Elecsys 2010 for measurement of BNP and NT-proBNP.
    Chien TI; Chen HH; Kao JT
    Clin Chim Acta; 2006 Jul; 369(1):95-9. PubMed ID: 16515777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma BNP and NT-proBNP assays by automated immunoanalyzers: analytical and clinical study.
    Bionda C; Bergerot C; Ardail D; Rodriguez-Lafrasse C; Rousson R
    Ann Clin Lab Sci; 2006; 36(3):299-306. PubMed ID: 16951271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and calibration of a new point-of-care test for the determination of NT-proBNP in whole blood.
    Bertsch T; Dikkeschei B; Gurr E; Hayen W; Jørgensen B; Lotz J; Müller-Bardorff M; Ordóñez-Llanos J; Schulz I; Spinke J; Thiele M; Zerback R
    Clin Lab; 2007; 53(7-8):423-31. PubMed ID: 17821946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 6 cardiac troponin assays in patients with acute coronary syndrome.
    Saadeddin SM; Habbab MA; Siddieg HH; Al Seeni MN; Tahery AB; Dafterdar RM
    Saudi Med J; 2003 Oct; 24(10):1092-7. PubMed ID: 14578975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of new immunoassays for the cardiac markers cTnI, myoglobin and CK-MB mass.
    Weber M; Rau M; Madlener K; Elsaesser A; Bankovic D; Mitrovic V; Hamm C
    Clin Biochem; 2005 Nov; 38(11):1027-30. PubMed ID: 16125162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imprecision of cardiac marker analyses among laboratories on the basis of external quality assurance results: Finnish experience.
    Penttilä IM; Laatikainen A; Penttilä K; Punnonen K; Rantanen T; Savolainen K; Tiikkainen U
    Scand J Clin Lab Invest; 2007; 67(5):507-18. PubMed ID: 17763187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cardiac assays on a benchtop chemiluminescent enzyme immunoassay analyzer, PATHFAST.
    Kurihara T; Yanagida A; Yokoi H; Koyata A; Matsuya T; Ogawa J; Okamura Y; Miyamoto D
    Anal Biochem; 2008 Apr; 375(1):144-6. PubMed ID: 18211813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results from a multicenter evaluation of the 4th generation Elecsys Troponin T assay.
    Hermsen D; Apple F; Garcia-Beltràn L; Jaffe A; Karon B; Lewandrowski E; Mühlbacher A; Müller R; Ordóñez J; Pagani F; Panteghini M; Plecko T; Jarausch J
    Clin Lab; 2007; 53(1-2):1-9. PubMed ID: 17323819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
    Hermsen D; Franzson L; Hoffmann JP; Isaksson A; Kaufman JM; Leary E; Müller C; Nakatsuka K; Nishizawa Y; Reinauer H; Riesen W; Roth HJ; Steinmüller T; Troch T; Bergmann P
    Clin Lab; 2002; 48(3-4):131-41. PubMed ID: 11934215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seemingly healthy 71-year-old men with minor elevations of cardiac troponin I and at risk of premature death in CVD have elevated levels of NT-proBNP: report from the ULSAM study.
    Venge P; Arnlöv J; Zethelius B
    Scand J Clin Lab Invest; 2009; 69(3):418-24. PubMed ID: 19221927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.